HLTRF - HLS Therapeutics GAAP EPS of -$0.11 revenue of $14.6M misses by $0.74M May, 05 2022 08:13 AM HLS Therapeutics Inc HLS Therapeutics press release (OTCPK:HLTRF): Q1 GAAP EPS of -$0.11. Revenue of $14.6M (+2.0% Y/Y) misses by $0.74M. For further details see: HLS Therapeutics GAAP EPS of -$0.11, revenue of $14.6M misses by $0.74M